Research peptides are not approved for human use in most countries including India. This page is for educational purposes only. Consult a physician before use.
Discovery and What Makes Humanin Unique
Humanin was discovered in 2001 by Nishimoto and colleagues, who were screening for factors that protect neurons from Alzheimer's disease pathology. They found a 21-amino acid peptide in surviving neurons from an Alzheimer's patient's brain that was dramatically cytoprotective — preventing cell death from amyloid-beta toxicity. They named it "humanin" reflecting its discovery in humans.
Like MOTS-c, Humanin is encoded in mitochondrial DNA — specifically in the 16S rRNA region. This makes it part of the growing family of mitochondria-derived peptides (MDPs) that act as signaling molecules communicating mitochondrial status to the rest of the cell and body.
What makes humanin particularly compelling for longevity research is that it is the first mitochondrial microprotein shown to be a circulating biomarker that predicts exceptional longevity in human observational studies.
The Centenarian Connection
The most compelling human data on Humanin comes from the centenarian offspring studies:
- Offspring of centenarians (people with at least one parent who lived to 100+) have significantly higher circulating humanin levels than age-matched controls whose parents had typical lifespans
- This effect persists after controlling for age, sex, BMI, and other variables
- The effect size is large enough to be biologically meaningful, not just statistically significant
- Humanin levels are lower in people with metabolic syndrome and type 2 diabetes
- Humanin levels decline with age in general population studies
These observations create a plausible hypothesis: higher humanin signaling may be one of the biological mechanisms underlying exceptional longevity. Whether raising humanin levels pharmacologically would translate to longevity benefits in humans is completely unknown.
Mechanism of Action
Humanin acts through multiple receptors and pathways:
- Receptor binding: Binds gp130/CNTFR complex (the IL-6 signal transducer), FPRL1 (formyl peptide receptor-like 1), and other receptors — acting as a pleiotropic ligand
- Anti-apoptotic: Inhibits BAX (pro-apoptotic protein) translocation to mitochondria, preventing cytochrome c release and caspase activation
- Neuroprotection: Reduces amyloid-beta toxicity, protects against ADCD (Alzheimer's disease-related cell death), reduces oxidative stress in neurons
- Metabolic effects: Sensitizes tissues to insulin signaling, reduces inflammatory cytokines (TNF-α, IL-6)
- STAT3 activation: Via gp130/JAK pathway → anti-apoptotic and proliferative signaling in various cell types
The Mitochondria-Derived Peptide Family
| Peptide | Size | Primary Action | Age-Related Decline | Human Data |
|---|---|---|---|---|
| Humanin | 21 aa | Cytoprotection, anti-apoptotic | Yes — strong age decline | Centenarian observational |
| MOTS-c | 16 aa | AMPK activation, metabolic | Yes — metabolic disease | None (intervention) |
| SHLP2 | 12 aa | Anti-apoptotic, metabolic | Yes | Very limited |
| SHLP3 | 7 aa | Energy metabolism | Yes | Very limited |
Research Status and Practical Context
Humanin research is at an early but exciting stage:
- No human intervention trials have been published
- Preclinical data is compelling across Alzheimer's, metabolic disease, and lifespan models
- Synthetic humanin is available from research peptide suppliers and is being studied in academic settings
- The centenarian offspring data provides unique human observational evidence linking humanin to longevity outcomes — rare in peptide research
There is no validated human dosing protocol for Humanin. Online protocols (various doses of synthetic humanin subcutaneously) are entirely speculative extrapolations from animal studies. Anyone using Humanin experimentally should understand this means operating without any established safety or efficacy data in humans.
Frequently Asked Questions
What is Humanin and why is it relevant to longevity?
Humanin is a 21-amino acid mitochondria-encoded microprotein discovered in 2001. It protects cells from apoptosis, reduces amyloid-beta toxicity in neurons, improves insulin sensitivity, and reduces inflammation. Its relevance comes from compelling observational data: offspring of centenarians have significantly higher humanin levels than age-matched controls.
Do centenarians have more humanin?
Offspring of centenarians have significantly higher circulating humanin levels than age-matched controls whose parents had normal lifespans. This is one of the most provocative observations in longevity biology — suggesting humanin may be a biological marker and possibly a contributor to exceptional longevity.
Humanin and Alzheimer's — what is the connection?
Humanin was originally discovered in surviving neurons from an Alzheimer's patient's brain, where it protected cells from amyloid-beta toxicity. It reduces amyloid-beta-induced apoptosis in neuronal cultures and improves memory in Alzheimer's mouse models. Humanin levels are lower in Alzheimer's patients than healthy controls.
Humanin vs MOTS-c — how do they compare?
Both are mitochondria-derived peptides encoded in mitochondrial DNA. Humanin is a cytoprotective peptide primarily protecting cells from death signals. MOTS-c is a metabolic regulator activating AMPK. They decline with age and metabolic disease and are complementary members of the mitochondria-derived peptide family.